|Articles|April 1, 2016

Redefining Easy

The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada, offers a broad range of products that span from research and development to production. Visit booth #2841 to learn how our new product innovations will help you simplify your manufacturing processes, allowing you to advance your molecules to market faster and more cost effectively.

MilliporeSigma
INTERPHEX Booth #2841

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Redefining Easy

Newsletter

Trending on BioPharm International

Charles River Incubator Cohort to Accelerate CGT Development

GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale

BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing

FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways

Navigating the Next Wave of Biopharma Manufacturing Innovation